Alterity Therapeutics Limited (ATHE)
NASDAQ: ATHE · Real-Time Price · USD
4.575
-0.090 (-1.93%)
Jul 28, 2026, 11:42 AM EDT - Market open
Alterity Therapeutics Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 8.84 | 7.64 | 4.02 | 3.92 | 5.12 | 4.49 | |
Revenue Growth | 15.67% | 90.12% | 2.63% | -23.56% | 14.23% | 3554.58% |
Gross Profit | 8.84 | 7.64 | 4.02 | 3.92 | 5.12 | 4.49 |
Selling, General & Admin | 7.61 | 5.48 | 4.76 | 5.06 | 5.51 | 6.94 |
Research & Development | 16.53 | 14.4 | 18.64 | 13.2 | 14.75 | 12.28 |
Other Operating Expenses | 0.38 | 0.21 | 0.22 | 0.33 | 0.37 | 0.43 |
Total Operating Expenses | 24.53 | 20.1 | 23.63 | 18.59 | 20.63 | 19.65 |
Operating Income | -15.69 | -12.46 | -19.61 | -14.67 | -15.5 | -15.16 |
Interest Income | 1.24 | 0.45 | 0.27 | 0.02 | 0 | 0.02 |
Other Non-Operating Income (Expense) | -0.02 | -0.07 | 0.26 | 0.92 | -2.72 | -0.3 |
Total Non-Operating Income (Expense) | 1.23 | 0.38 | 0.53 | 0.93 | -2.72 | -0.28 |
Pretax Income | -14.46 | -12.08 | -19.08 | -13.7 | -12.78 | -15.31 |
Provision for Income Taxes | -0.13 | -0.07 | -0.05 | -0.1 | -0.07 | - |
Net Income | -14.33 | -12.01 | -19.03 | -13.6 | -12.71 | -15.31 |
Net Income to Common | -14.59 | -12.15 | -19.12 | -13.81 | -12.85 | -15.31 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 0 | 0 | 0 | 0 | 0 | - |
Shares Outstanding (Diluted) | 0 | 0 | 0 | 0 | 0 | - |
Shares Change | 38.04% | 75.31% | 50.29% | 0.91% | - | - |
EPS (Basic) | -42.00 | -57.00 | -156.00 | -171.00 | -159.00 | - |
EPS (Diluted) | -42.00 | -57.00 | -156.00 | -171.00 | -159.00 | - |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Free Cash Flow | -10.62 | -11.45 | -12.61 | -20.04 | -12.43 | -17.34 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -36.08 | -53.70 | -103.69 | -247.67 | -154.94 | - |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -177.49% | -163.04% | -487.82% | -374.60% | -302.56% | -338.10% |
Profit Margin | -162.13% | -157.19% | -473.50% | -347.20% | -248.01% | -341.33% |
FCF Margin | -120.16% | -149.86% | -313.78% | -511.78% | -242.54% | -386.62% |
EBITDA | -15.69 | -12.32 | -19.46 | -14.57 | -15.45 | -15.09 |
EBITDA Margin | -177.49% | -161.22% | -484.15% | -371.99% | -301.51% | -336.42% |
EBIT | -15.69 | -12.46 | -19.61 | -14.67 | -15.5 | -15.16 |
EBIT Margin | -177.49% | -163.04% | -487.82% | -374.60% | -302.56% | -338.10% |
Effective Tax Rate | 0.90% | 0.56% | 0.24% | 0.76% | 0.55% | 0.00% |